Skip to content
Staging environment — review version. Do not share.

VNS and DBSResearch Radar

Understanding the brain’s reward system in deep brain stimulation for depression

For patients with treatment-resistant depression (TRD) — those who do not respond to multiple antidepressant trials — deep brain stimulation (DBS) offers an option…

By João L. de Quevedo, MD, PhD

Published on · Last reviewed on · 2 min read

For patients with treatment-resistant depression (TRD) — those who do not respond to multiple antidepressant trials — deep brain stimulation (DBS) offers a promising, yet still experimental, option. Recent research published in Molecular Psychiatry explores how brain activity within the reward circuit relates to treatment outcomes following DBS targeting the ventral anterior limb of the internal capsule (vALIC).

What did the researchers study?

The reward circuit, which includes the nucleus accumbens (NAc), caudate nucleus, and midcingulate cortex, regulates how we experience pleasure and motivation — functions often impaired in depression. Researchers at Amsterdam UMC investigated whether brain activity in these regions could predict who benefits most from vALIC DBS.

Fifteen patients with severe TRD underwent functional magnetic resonance imaging (fMRI) before and after DBS surgery, performing a task that simulated winning or losing money. The team compared their brain activity with that of healthy volunteers and examined how reward processing changed after DBS treatment.

Key findings

  • Baseline brain activity predicted outcomes:

Patients with lower NAc activation during “loss anticipation” and higher caudate and midcingulate activation during “reward feedback” tended to have poorer treatment outcomes.

  • DBS improved symptoms but did not alter overall reward processing:

Although patients showed a significant reduction in depression severity, their overall brain reward responses did not differ significantly from those of healthy controls after treatment.

  • A new clue emerged:

Those who showed greater activation in the middle frontal gyrus (MFG) after DBS — an area involved in decision-making and emotional regulation — showed greater clinical improvement.

Why this matters

These results suggest that individual differences in reward circuit function may help explain why some patients benefit from DBS and others do not. The results also highlight the middle frontal gyrus as a potential biomarker or complementary target for future interventions, possibly linking DBS outcomes to noninvasive neuromodulation therapies, such as repetitive transcranial magnetic stimulation (rTMS).

As we move toward precision psychiatry, understanding these brain-based predictors may one day help clinicians personalize interventional treatments, improving response rates for those struggling with refractory depression.

Related content